Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients-Reference-Cited by-同舟云学术

Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients

Published:2024-03-01 Issue:3 Volume:310 Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Ayyagari Raj^ORCID,Rahman Saumik Z.^ORCID,Grizzard Kevin^ORCID,Mustafa Adel^ORCID,Staib Lawrence H.^ORCID,Makkia Rasha S.^ORCID,Bhatia Shivank,Bilhim Tiago^ORCID,Carnevale Francisco C.^ORCID,Davis Clifford,Fischman Aaron^ORCID,Isaacson Ari,McClure Timothy,McWilliams Justin^ORCID,Nutting Charles^ORCID,Richardson Andrew^ORCID,Salem Riad^ORCID,Sapoval Marc,Yu Hyeon^ORCID

Publisher

Radiological Society of North America (RSNA)

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.231877

Reference28 articles.

1. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)

2. Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review

3. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial

4. Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period

5. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia